Telmisartan Lowers Elevated Blood Pressure in Psoriatic Mice without Attenuating Vascular Dysfunction and Inflammation
Background: Psoriasis is hallmarked by vascular dysfunction, arterial hypertension, and an increased risk for cardiovascular diseases. We have shown recently that skin-driven interleukin (IL)-17A expression promotes psoriasis-like disease in mice, and this is associated with vascular inflammation, v...
Main Authors: | Johannes Wild, Rebecca Schüler, Tanja Knopp, Michael Molitor, Sabine Kossmann, Thomas Münzel, Andreas Daiber, Ari Waisman, Philip Wenzel, Susanne Helena Karbach |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/20/17/4261 |
Similar Items
-
A multicenter, open-label study of the efficacy and safety of telmisartan in mild to moderate hypertensive patients
by: Plavnik Frida Liane, et al.
Published: (2002-01-01) -
The Antihypertensive Efficacy of Chlorthalidone and Telmisartan in Indian Hypertensive Patients who were Uncontrolled with Hydrochlorothiazide and Telmisartan Combination-A Prospective and an Open Label Study
by: Suresh V Sagarad, et al.
Published: (2014-04-01) -
Features of change of intracardiac gemodynamics and functional state of myocardium under the impact of telmisartan in patients with hypertension
by: Koshlia V.I., et al.
Published: (2016-09-01) -
Features of change of intracardiac gemodynamics and functional state of myocardium under the impact of telmisartan in patients with hypertension.
by: V. I. Koshlia, et al.
Published: (2015-09-01) -
Effect of Telmisartan on the Regression of the Left Ventricular Hypertrophy in the Patients of Essential Hypertension
by: Kumar Haraprasad Misra, et al.
Published: (2013-07-01)